Cargando…
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
After introduction of new direct acting antivirals (DAAs) against hepatitis C, the cure rate has increased substantially especially in patients with liver cirrhosis. Decreased but remaining risk for hepatocellular carcinoma (HCC) has been shown in patients with liver cirrhosis after cure, in previou...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918700/ https://www.ncbi.nlm.nih.gov/pubmed/30288315 http://dx.doi.org/10.1186/s41124-016-0019-3 |